Skip to main content
All lobbying filings

LMH STRATEGIC SOLUTIONS

LMH STRATEGIC SOLUTIONS filed a Q3 report for MIDSIZED BIOTECH ALLIANCE OF AMERICA (MBAA) on October 19, 2026, reporting $120,000 in lobbying income.

Lobbying for MIDSIZED BIOTECH ALLIANCE OF AMERICA (MBAA) · Represents and protects the interests of midsized biopharmaceutical innovators.

All filings by LMH STRATEGIC SOLUTIONS · Everything MIDSIZED BIOTECH ALLIANCE OF AMERICA (MBAA) has reported

 Filing · LD-2 quarterly report Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 19, 2026
Income
$120,000
What the client paid this registrant for the period.
Client based in
District of Columbia

Official filing document

 Lobbyists on this filing 3
  • ALANNA TEMME
    Previously held: Legislative Director, U.S. Representative Jon Porter
  • AMY CHEVALIER EFANTIS
    Previously held: Legislative Director, Rep. Artur Davis; Legislative Assistant, Rep. Tom Barrett
  • SOPHIE KHANAHMADI
    Previously held: Legislative Asst., Rep. Martha Roby; Legislative Asst., Rep. Lee Terry; Staff Asst./LC, Senator Jeff Sessions

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 2

Prescription drug payment reform. Pharmaceutical Supply Chain.

General Medicare and Medicaid Issues.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem